|
667 OFT sets out
plan to limit impact of supply changes Recommendations
to limit the impact of direct-to-pharmacy (DTP) distribution deals on
the NHS drugs bill and service levels to pharmacies have been made to
the Government by the Office of Fair Trading this week
PJ 2007;279:667
Full Text
667 Professional body needs authoritative
voice Any future professional body for
pharmacy must be vocal and speak on behalf of all pharmacists and pharmaceutical
scientists, the National Pharmacy Association believes
PJ 2007;279:667
Full Text
667 Council supports two-hour maximum absence
for responsible pharmacists The Council of the Royal Pharmaceutical Society, after a named vote, has agreed with a recommendation made by the Society’s law and ethics committee that responsible pharmacists should only be absent from a pharmacy for a maximum of two hours per day
PJ 2007;279:667
Full Text
668 Authentication systems
could reduce error rates Authentication of dispensed
items, using barcodes or radio-frequency identification tags, could have a positive
impact on dispensing accuracy, according to researchers who have conducted the
most comprehensive study of dispensing errors in UK community pharmacies to date
PJ 2007;279:668
Full Text
668 Phasing out of prescription charges by 2011
welcomed in Scotland Scottish pharmacy organisations have responded positively to last week’s announcement that NHS prescriptions charges will be phased out in Scotland by 2011
PJ 2007;279:668
Full Text
668 Consultation on midwife supply launched Plans
to bring the range of medicines that midwives are able to sell, supply or administer
in line with modern practice have been put out for consultation by the Medicines
and Healthcare products Regulatory Agency
PJ 2007;279:668
Full Text
668 First GMC retention fee rise for six years Annual
retention fees for the General Medical Council are to rise for the first time
in six years
PJ 2007;279:668
Full Text
669 Educate parents and children
about atopic eczema Health care professionals should
spend time educating children with atopic eczema and their parents or carers
about the condition and its treatment, according to a National Institute for
Health and Clinical Excellence guideline published this week
PJ 2007;279:669
Full Text
669 Esomeprazole and fondaparinux accepted for
use in NHS Scotland Esomeprazole (Nexium) and fondaparinux (Arixtra) are both given the green light for use in Scotland this month as part of the Scottish Medicines Consortium’s latest guidance
PJ 2007;279:669
Full Text
669 Pharmacies to supply oral contraception
without prescription Oral contraception is to be
made available from community pharmacies without a prescription
PJ 2007;279:669
Full Text
669 Scottish plan for primary care Measures to improve access to primary care services in Scotland are the focus of the Scottish Government’s action plan “Better health, better care”, launched by Health Secretary Nicola Sturgeon this week
PJ 2007;279:669
Full Text
670 Former PMI manager claims
the business is worth much more than the NPA has offered to pay for it Members
of the Pharmacy Mutual Insurance Company are being asked to approve the sale
of its renewal rights for less than their true value, according to former National
Pharmacy Association insurance director Glenn Hirchfield. Mr Hirchfield was one
of the three people who blocked the approval of the sale on 7 November 2007
PJ 2007;279:670
Full Text
670 PSNC highlights pharmacy to Darzi review Three areas in which the development of community pharmacy services will help achieve the Government’s aim of shifting health care from secondary to primary care services have been highlighted by the Pharmaceutical Services Negotiating Committee
PJ 2007;279:670
Full Text
670 Minister gives pharmacists green light to
invest for future Creating an environment that gives pharmacy businesses confidence to invest is important, Dawn Primarolo, the Government minister responsible for pharmacy in England, said at this week’s Royal Pharmaceutical Society Council dinner
PJ 2007;279:670
Full Text
671 Patients link morphine
with death Cancer patients interpret the offer of morphine for pain relief as a signal that the health professional caring for them believes they are dying, a UK study suggests. This, in turn, can lead to refusal of pain relief and a reduction in patients’ quality of life
PJ 2007;279:671
Full Text
671 Standardised sepsis care leads to US award Standardising
the care of patients with sepsis has reduced mortality at a US hospital
PJ 2007;279:671
Full Text
671 Paul Gimson new CEO at Community Pharmacy
Wales Paul Gimson has been appointed chief executive
officer of Community Pharmacy Wales
PJ 2007;279:671
Full Text
671 Doxycycline shows promise in relapsing multiple
sclerosis Combination therapy with interferon beta-1a
and doxycycline is effective and well tolerated for patients with relapsing-remitting
multiple sclerosis (RRMS), a paper published online this week suggests
PJ 2007;279:671
Full Text
671 Social care reform announced A
major reform of the adult social care system was announced this week by Health
Secretary Alan Johnson
PJ 2007;279:671
Full Text
671 Palliative care funding Funding for palliative care model schemes in Scotland will continue during 2007–08
PJ 2007;279:671
Full Text
671 Bivalirudin alone for ACS Bivalirudin
alone produces similar outcomes after one year, in terms of death, myocardial
infarction or unplanned revascularisation, as two anticoagulant regimens in patients
with acute coronary syndromes who have undergone early invasive treatment
PJ 2007;279:671
Full Text
671Delaying Alzheimer’s disease Cholinesterase inhibitors do not delay the appearance of Alzheimer’s disease or other forms of dementia, a review of data suggests
PJ 2007;279:671
Full Text
671 Smoking cessation funds Scottish
health boards will continue to receive funding for smoking cessation services
next year (2008)
PJ 2007;279:671
Full Text
672 Parents rate honey for
children’s night-time cough Parents rated
honey, but not dextromethorphan, as better than no treatment for relieving nocturnal
cough in children in a US study published last week
PJ 2007;279:672
Full Text
672 Co-op pharmacy chain grows About half the pharmacies operated by PCT Healthcare Group under the Peak Pharmacy and Tims & Parker names have been sold to the Co-operative Group, and will be incorporated into its Co-operative Pharmacy chain
PJ 2007;279:672
Full Text
672 Baclofen shows promise for alcoholics with
liver disease Baclofen can reduce drinking in alcoholic
patients with cirrhosis of the liver, a study published last week suggests
PJ 2007;279:672
Full Text
R&D news
673 New alternatives to imatinib emerge for
CML patients Positive results for a wave of new
treatments for chronic myeloid leukaemia patients who do not respond to imatinib
therapy were presented at the annual meeting of the American Society of Hematology
in Atlanta, Georgia, this week
PJ 2007;279:673
Full Text
673 Fine-grained imaging could detect response
to cancer treatment in days rather than weeks Response
to cancer treatment could be detected in hours rather than weeks by using enhanced
magnetic resonance imaging
PJ 2007;279:673
Full Text
673 Gene link to paclitaxel failure Treatment
of ovarian cancer with paclitaxel is more likely to fail in patients who lack
the ability to produce the TGFBI (transforming growth factor beta induced) protein
PJ 2007;279:673
Full Text
673 Intravascular nanoparticles Researchers
have demonstrated the feasibility of delivering drugs direct to areas of tissue
by triggering release from intravascular nanoparticles
PJ 2007;279:673
Full Text
673 Imatinib tweaked to target GISTs Researchers
have re-engineered imatinib to target gastrointestinal stromal tumours (GISTs)
more specifically and to mitigate cardiotoxic side effects
PJ 2007;279:673
Full Text
673 Amiloride could be MS treatment Amiloride
reduces degeneration of nerve tissue in mice with a condition that mimics multiple
sclerosis, according to research published online
PJ 2007;279:673
Full Text
673 New approach to type 2 diabetes A
range of small molecules that activate SIRT1 (an enzyme which controls pathways
associated with beneficial effects on glucose homeostasis and insulin sensitivity)
has been identified
PJ 2007;279:673
Full Text |
The
Pharmaceutical Journal